Home Genoox

Genoox

Genoox Collaborates with Bionano to Enhance the Detection of Disease Causing Structural Variants in DNA

4/16/18: Based on initial outcome data and the potential to enhance research in the area of rare diseases, the Center for Genetic Medicine Research at Children's National Health System in Washington D.C., which is ranked #1 in the Nation by U.S News for babies and top 10 children’s hospital overall, will be the initial user of the Genoox integrated platform. The new technology offers Children’s National a single platform for sensitive, accurate detection of structural variations and genetic mutations for rare disease, not previously possible, helping to speed genetic diagnosis for children and families.